Soluble ST2 and galectin-3 in pediatric patients without heart failure

2013 ACCF/AHA Guideline for the Management of Heart Failure

Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt et al. · Journal of the American College of Cardiology · 2013 · 12.6K citations

Medicine, Cardiology, Internal Medicine +14

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt et al. · Circulation · 2013 · 3.3K citations

Medicine, Cardiology, Cardiothoracic Surgery +15

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

Rudolf A. de Boer, Dirk J. Lok, Tiny Jaarsma et al. · Annals of Medicine · 2010 · 589 citations · Full text

Medicine, Cardiology, Molecular Medicine +17

Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure

Shafiq Rehman, Thomas Mueller, James L. Januzzi · Journal of the American College of Cardiology · 2008 · 381 citations

Medicine, Cardiology, Immunology +14

Soluble ST2, High-Sensitivity Troponin T- and N-Terminal Pro-B-Type Natriuretic Peptide: Complementary Role for Risk Stratification in Acutely Decompensated Heart Failure

Domingo A. Pascual‐Figal, Sergio Manzano‐Fernández, Miguel Gómez-Boronat et al. · European Journal of Heart Failure · 2011 · 259 citations · Full text

Medicine, Cardiology, Critical Care Cardiology +13